home mail sitemap    ruen

Registration Lost password?

  • About
  • Services
  • Collaboration
  • Useful info
  • — Regulatory baseonly for registered users
  • Role in Drug Development
  • Toxicology
  • Nanosafety
  • Clinical Expertise
  • Why Russia?

Mission

To assist the fast growing need of pharmaceutical development community in bringing new therapeutics to the market in compliance with international standards, while placing a particular emphasis upon communication, speed and quality.

To integrate the Russian innovative biomedical science into the global development of new therapeutics for the benefit of consumers around the world.

info@bonasana.org phone

News

  • Revisiting the Toxic Substances Control Act of 1976
  • Mama, Dada, and Nano?
  • Organising Committee of Nanotoxicology 2010 Announces Opening of Early Bird Registrations and Abstract Submissions
  • Microanalysis System for Rapid Mercury Detection
  • New Study Reveals Popular Nanoparticle Bactericidal Agent is Toxic to Fish
  • Research Highlight Potential Toxicity of Nanoparticles in Sunscreens
  • NPL Supports HPA to Advance Research on Toxicology of Nanoparticles
  • Zinc Oxide Nanoparticles Used in Suncreens are Toxic to Colon Cells
  • Cluster bomb for cancer care: Nano-vehicles to deliver chemotherapy treatments on target
  • Topical treatment for quantum dots?

News archive

Events

  • ECB 2010 - European Congress on Biotechnology
  • International Conference on Nanotechnology:Fundamentals and Applications

Events archive


Copyright 2010 Bonasana. All rights reserved.
Developed by Logic Softworks, LLC